Nuclear Medicine

Share:

EmailFacebookLinkedInXWhatsAppShare
This program supports the research and development of technologies and techniques that create images using gamma-ray (SPECT) or positron (PET) emissions from radioactive biological agents that are injected, inhaled, or ingested into the body.

Emphasis

The emphasis is on: simulation and development of new detectors, collimators, and readout methods that enhance the signal quality of detecting isotope emissions; designs of novel camera geometries; and correction methods that compensate for the radiation physics properties to improve the clinical reliability of the image. Of interest are improvements and corrections for interaction events in PET detectors and enhancement to time of flight (TOF) image generation methods (reconstructions algorithms); as well as new collimator and camera designs for SPECT.

Relevance

The emphasized topics are meant to lead toward: improved clinical PET and SPECT cameras or next-generation camera systems; novel simulations, reconstruction algorithms, or artifact corrections for enhancing diagnostic images; and combined camera designs. Investigating the associated dosimetry estimations leads to decreased risk in diagnostic imaging studies in patients.

Additional emphasis

  • coupling of positron emission tomography (PET) and single photon emission computed tomography (SPECT) to CT and/or to MRI (or other modalities)
  • evaluation of new semiconductor detectors and scintillators
  • readout electronics for measuring radiation interactions
  • techniques for improved camera spatial resolution and sensitivity
  • replacing photomultiplier tubes with novel photoconversion techniques 
  • new approaches for improving coincidence measurements for TOF-PET
  • application of secondary emissions (bremsstrahlung, Cherenkov) for imaging
  • novel camera designs applicable to imaging specific organs
  • combining modalities for clinically relevant hybrid systems
  • software algorithms to estimate patient dosimetry

Additional support

  • design of improved spatial and temporal resolution SPECT systems
  • methods of measuring and correcting for patient motion
  • new diagnostics applied to image-guided therapy and theranostics
  • development of imaging molecular agents is supported by the Molecular Imaging program
  • novel evaluation of images is supported by the Image Processing, Visual Perception and Display program
  • clinical application of image-guided therapy and theranostics is supported by the Image-Guided Interventions program

Notice of Special Interest in Radiation Monitoring for Trauma Care

 

    Related News

    March 14, 2024
    Researchers at The Pennsylvania State University have developed a new synergistic approach to revascularization that combines a new framework (scaffold) made from granular hydrogels with a surgical technique called micropuncture. Their preclinical method could rapidly grow organized blood vessels in live rats.
    March 7, 2024
    In recognition of International Women’s Day (March 8), we’re featuring Rebecca Richards-Kortum, Ph.D., a longtime bioengineer in academia who has contributed globally to improving women's health.
    March 4, 2024
    What if bacteria—which love to grow deep inside tumors—could guide cancer therapies directly to their target? NIH-funded researchers have engineered a bacterial strain to “light up” tumors so that reprogrammed T cells, drawn like a moth to a flame, can find and destroy them. Their preclinical treatment could potentially be effective against any solid tumor type.
    February 27, 2024
    A collaborative team of NIH-funded researchers is developing a way to obtain DNA shed from brain tumors using focused ultrasound. Their first-in-human study could be an important step towards improving the way brain tumors are diagnosed.
    February 5, 2024

    Researchers from Brigham and Women’s Hospital and the Massachusetts Institute of Technology (MIT) have unveiled detailed images of brain cancer tissue using a new microscopy technology called decrowding expansion pathology (dExPath). Source: Brigham and Women's Hospital